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WI ABSTRACT 
Normal mammalian tissue and the culturing process has 
been developed for the three groups of organ, structural and 
blood tissue. The cells are grown in vitro under microgravity 
culture conditions and form three dimensional cells aggre- 
gates with normal cell function. The microgravity culture 
conditions may be microgravity or simulated microgravity 
created in a horizontal rotating wall culture vessel. 
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METHOD FOR PRODUCING 
MAMMALIAN TISSUE AND CELL 
AGGREGATES UNDER MICROGRAVITY 
CULTURE CONDITIONS AND THE 
PRODUCTS PRODUCED THEREFROM 
NON-NEOPLASTIC, THREE DIMENSIONAL, 
ORIGIN OF THE INVENTION 
The invention described herein was made in the perfor- 
mance of work under a NASA contract and is subject to the 
provisions of Section 305 of the National Aeronautics and 
Space Act of 1958, Public Law 85-568 (72 Star. 435; 42 
U.S.C. 2457). 
RELATED PATENTS AND APPLICATIONS 
This application is a continuation-in-part of U.S. appli- 
cation Ser. No. 07/939,791, filed on Sep. 3, 1992, now U.S. 
Pat. No. 5,308,764, which is a continuation of U.S. appli- 
cation Ser. No. 07/317,931, filed on Mar. 2, 1989, now U.S. 
Pat. No. 5,153,132, which is a continuation-in-part of U.S. 
application Ser. No. 07/317,776, filed on Mar. 2, 1989, now 
U.S. Pat. No. 5,155,034, which is a continuation-in-part of 
US. application Ser. No. 07/213,558, filed on Jun. 30,1988, 
now U.S. Pat. No. 5,026,650, and a continuation-in-part of 
US .  application Ser. No. 07/213,559, filed on Jun. 30, 1988, 
now U.S. Pat. No. 4,988,623, and a continuation-in-part of 
U.S. application Ser. No. 071625,345, filed on Dee. 11,1990, 
now U.S. Pat. No. 5,153,131. 
FIELD OF THE INVEhTlON 
The invention relates to production of functional three 
dimensional mammalian tissue from a culture of normal 
cells in fluid media. 
BACKGROUND OF THE INVENTION 
The culturing of mammalian cells presents many chal- 
lenges as compared to bacteria, yeast and molds. Bacterial- 
type cells have tougher outer cell walls and can be manipu- 
lated without injuring the cells during culture, whereas 
mammalian cells are delicate and cannot withstand stress. 
Bacterial-type cells are not organized into functional tissue 
groups with cell differentiation or organization as seen in 
higher life forms such as mammals. 
Mammalian tissue can be grouped into three general 
categories of (1) organ tissue (2) structural tissue and (3) 
blood producing tissue. Mammalian tissue is composed of 
aggregates of cells that share a functional interrelationship in 
order to have tissue growth. Mammalian tissue is composed 
of different types of cells characterized by different mor- 
phology and immunochemical properties. Cellular differen- 
tiation in mammals involves complex interactions in which 
cell membrane junctions, extracellular matrices such as 
basement membrane and ground substances. Soluble signals 
produced and shared among the cells play an important role. 
Study of normal mammalian tissue, however, has been 
limited because of lack of adequate in vitro culture systems 
that product tissue of sufficient size and functionality. In 
contrast, tumor cells are by their nature easier to grow in 
vitro, possess abnormal growth characteristics and do not 
behave like normal cells in their interaction with neighbor- 
ing cells. Sutherland, “Cell and Environment Interactions in 
Tumor Microregions: The Multicell Spheroid Model”, Sci- 
ence, Vol. 240, pp. 177-240, 8 Apr. 1988. Different culture 
methods for normal and abnormal mammalian cells have 
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2 
been used. Elaborate culture systems for normal mammalian 
cells have been developed in an attempt to grow normal 
tissue. 
A variety of different cells and tissues, such as bone 
marrow, skin, liver, pancreas, mucosal epithelium, adeno- 
carcinoma and melanoma, have been grown in culture 
systems to provide three dimensional growth in the presence 
of a preestablished stromal support matrix. U.S. Pat. No. 
4,963,489, Three-Dimensional Cell and Tissue Culture Sys- 
tem, Naughton, et al., Oct. 16, 1990; U.S. Pat. NO. 5,032, 
508, Three-Dimensional Cell and Tissue Culture System, 
Naughton, et al., Jul. 16, 1991. A biocompatible, non-living 
material formed into a three dimensional structure is inocu- 
lated with stromal cells. In some cases, the three dimen- 
sional structure is a mesh pre-coated with collagen. Stromal 
cells and the associated connective tissue proteins naturally 
secreted by the stromal cells attach to and envelop the three 
dimensional structure. The interstitial spaces of the structure 
become bridged by the stromal cells, which are grown to at 
least subconfluence prior to inoculating the three dimen- 
sional stromal matrix with tissue-specific cells. 
Normal mammalian tissue has been grown for limited 
periods of time as two-dimensional monolayers on gelled 
substrate or other surface for anchoring the cells. Adult 
colonic epithelial cells have been found to be more difficult 
to culture than fetal colonic epithelial cells. Buset et al. 
“Defining Conditions to Promote the Attachment of Adult 
Human Colonic Epithelial Cells”, In Vitro Cell. & Dev. B i d . ,  
Vol. 23. No. 6 pp. 403-412 (June 1987). To mimic a more 
normal environment using monolayer culture, cocultures 
were prepared using two cell types, often with a “feeder 
layer” of fibroblasts or other cells to supply the primary cells 
with nutrients and other factors difficult to incorporate into 
a substrate and to provide the cellular interaction believed to 
be necessary for the production of differentiated tissue. Reid 
et al., “Culturing Hepatocytes and Other Differentiated 
Cells”, Hepufology, Vol. 4, No. 3, pp. 548-559 (1984); 
Haake et al. “Retention of Differentiated Characteristics in 
Human Fetal Keratinocytes In Vitro”, In Vitro Cell. & Dev. 
Biol., Vol. 25 No. 25 pp. 592-600 (July 1989). Also, 
monolayers “conditioned” with fibroblast cells have been 
used to impart into the substrate the soluble growth factors 
for epithelial cells, Kabalin et al. “Clonal Growth of Human 
Prostatic Epithelial Cells Is Stimulated by Fibroblasts”, The 
Prostate, Vol. 14, pp. 251-263 (1989). Monolayers do not 
produce a three dimensional tissue, but rather a two-dimen- 
sional spread of cells. Often the cells developed by mono- 
layer culture and coculture become undifferentiated and lack 
normal function. 
Three dimensional in vitro models of differentiated tissue 
have been produced, however, the cells often do not dem- 
onstrate normal cellular activity. Embryonic avian skeletal 
muscle cells have been grown in vitro on expandable 
membranes which are gradually and substantially, continu- 
ously stretched to simulate the mechanical stimulation of 
cells experienced in vivo. U.S. Pat. No. 4,940,853, Method 
for Growing Tissue Specimens in Vitro, Vadenburgh, Jul. 10, 
1990. The expandable support membrane supports develop- 
ment of three dimensional structures which more closely 
resemble tissue grown in vivo, however, normal indepen- 
dent cellular activity was not identified. Additionally, three 
dimensional human mammary epithelial cells have been 
grown in collagen. U.S. Pat. No. 5,026,637, Soule, et al., 
Jun. 25, 1991. However, the cells, under the culture condi- 
tions, did not undergo terminal differentiation and cell 
senescence, but rather were “immortal” in that they retained 
the capacity to divide forever. Thus, normal cellular activity 
and naturalization was not observed. 
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The study of the organ systems exemplifies the complex lations were then utilized to encourage chondrocyte expan- 
interrelationship of neighboring cells in mammalian tissue sion and differentiation, and the deposition of proteoglycan 
necessary for normal three dimensional tissue growth. Mam- into the interstitial matrices. These maneuvers include vari- 
malian organ systems have been studied to determine the ous growth factor augmentations, an effort to emulate in situ 
relationship of the cell types that make UP the Organ as well 5 conditions. The extent to which the cells can be maintained 
as their effects on each other. Studies on normal tissue in situ is on the order of tens of years as Seen in the 
differentiation have indicated an important interaction adult. ~ ~ ~ ~ ~ ~ ~ ~ l ~ ,  in standard cell culture the extent which 
between epithelial cells and mesenchymal cells and the cells can be maintained in a growth phase or a normal static 
production and differentiation of the cells from fibroblasts. maintenance phase is on the order of 22 days. It has been 
Kaye et al.3 Sheath 10 demonstrated that multiple cell-surface receptors exist that Replication, Migration, and Cytodifferentiation of a Mesen- are important in cellular growth and differentiation, and chymal Cell System in Adult Tissue” Gustroenterology, Vol. 
60. No. 4, pp. 515-536 (1971). Furthermore, small intestine extracellular matrix formation. surface receptors are 
tissue is exemplary of organ tissue types with epithelial cells labile to destructive surface sheer. 
with functional brush borders and organized columnar cells Cartilage cells were reportedly cultured for 13 months 
associated with mesenchymal cells. Other organs have sifi- l5 Using a solid substrate in Conventional Culture Vessels. U.S. 
lar organization. Small intestine tissue has physical support Pat. No. 4,757,017 Cheung et al., Jul. 12, 1988. The solid 
in vivo SO that the tissue forms crypts which increase the substrate was a porous calcium compound. Multilayer cell 
surface area of the organ, In addition to the crypt formation growth was observed and the cells maintained their pheno- 
Pericryptal 
in vivo, there are also immunocytochemical markers for type. 
particular cell types with normal functionality as well as cell 2o Bone marrow has been grown using conventional mono- 
types that are in developmental phases to produce functional layer cell culture technique. Human bone marrow cell cul- 
organ tissue. ture technique. Human bone marrow cell production 
Immunochemical properties further characterize normal declines over time in monolayer culture. Naughton et. al. 
cells types and tissue. Keratin, vimentin and Factor VID 25 disclosed a bone marrow Culture System in CO-Culture With 
antibodies detect epithelial, fibroblastic and endothelial cells Stromal Cells O r  mixtures of cell types on a three dimmional 
respectively. Villin is a cytoskeletal protein only found in Support. pat. No- 4,963,489. The three dimensional 
epithelial cells from the small intestine and colon. The Support was coated by cells Such as fetal fibroblasts Over a 
angioblast marker is present in certain precursor endothelial collagen layer on a mesh Support. 
cells, particularly dividing cells. Sucrase is an enzyme found 3o . Mammalian tissue has been grown in bioreactors provid- 
in the epithelial cell brush border of the small intestine. mg low shear from abnormal cell types such as tumor cells 
Basement membrane and extracellular matrix to compo- or cocultures with normal and tumor cells. Goodwin et al., 
nents such as laminin, fibronectin, Collagen IV, and pro- “Morphological Differentiation of Colon Carcinoma Cell 
teoglycan are associated with ordering of tissue and cellular Lines HT-29 and Hl-29K in Rotating-Wall Vessels,” In Vitro 
polarity. Basement membrane and extracellular matrix 35 Cell. Dev. Biol. Vol. 28A, pp. 47-60, January 1992. The 
development has been related to epithelial-mesenchymal bioreactor designs are disclosed in U.S. Pat. Nos. 4,988,623; 
development and differentiation. All these components are 5,026,650 and 5,153,131. Co-culture of tumor and normal 
necessary for normal tissue growth. cells in solid-state culture has been reported as shown in 
as large-scale three dimensional configurations has not been 40 However, Since tumor Or abnormal Cells P J W  under Condi- 
shown with routinely used in vitro culture technology. tions that normal cells cannot tolerate, the growth of non- 
Chantret et al., ‘‘Epithelial polarity, Villin Expression and normal Cells does not predict success for normal mammalian 
Eterocytic Differentiation of Cultured Human Colon Carci- Culture under the same or similar culture conditions. 
noma Cells: A survey of Twenty Cell Lines” Cancer Res., There are many potential uses of artificially produced 
Vol. 48, pp. 1936-1942 (Apr. 1, 1988). Factors that control 45 tissue for different mammalian systems. For example, small 
proliferation and differentiation in the gastrointestinal tract intestine tissue can be used as a model for the molecular and 
remain largely unknown. Corps et al., “Stimulation of Intes- clinical treatment of diseases such as inflammatory bowel 
tinal Epithelial Cell Proliferation in Culture by Growth disease (Crohn’s, ulcerative colitus), malabsorptive syn- 
Factors in Human and Ruminant Mammary Secretions” J. dromes (short-gut syndrome), numerous infectious diseases 
Endom, Vol. 113, pp. 285-290 (3 Nov. 1986); O’Loughlin 50 and tumors of the small bowel. The tissue can be a model for 
et al., “Effect of Epidermal Growth Factor on Ontogeny of the therapeutic trials prior to in vivo experimentation. How- 
the Gastrointestinal Tract” Am. J. Physiol., Vol. 249, pp. ever cultures longer than 7 weeks have been difficult to 
G674-G678 (8 Jul. 1985); Blay et al., “Contradistinctive achieve, since crypt cells are unable to survive standard 
Growth Responses of Cultured Rat Intestinal Epithelial culture regimens, and two-dimensional organ cultures do not 
Cells to Epidermal Growth Factor Depending on Cell Popu- 55 support the de novo assembly of stroma and its contribution 
lation Density” J. of Cell. Physiol., Vol. 129, pp.343-346 (15 to epithelial cell growth. Shamsuddin, “Colon Organ Culture 
Jul. 1986). as a Model for Carcinogenesis”, Colon Cancer Cells, Moyer 
Cartilage tissue is exemplary of normal structural tissue. and Paste, MS. Academic press, h c .  1990. 
Attempts have been made to encourage cartilage formation Also, a mammalian structural tissue such as a cartilage 
in vitro by culturing chondrocytes. Typical culture durations 60 model of high fidelity is important in clinical studies. There 
achieved in the more successful instances range from 10 are numerous maladies associated with cartilage, including 
days to 30 days, the 30-day point being a transition towards but not limited to knee-joint injuries, back injuries, articular- 
static culture or cellular degeneration and death. The success surface injuries, inflammatory diseases such as arthritis and 
achieved to date has had limited 3-dimensionality. Typical temporal-mandibular joint disease. Beyond the diseases are 
cell culture methodologies include isolating chondrocytes 65 the natural processes of maturation through puberty and the 
from various articular surfaces and plating the isolated geriatric inability to repair and maintain articular surfaces. A 
chondrocytes as a monolayer in a T-flask. Various manipu- tissue model would be beneficial for the analyses and 
culture of normal or neoplastic small intestine epithelium U.S. Pat. NO. 4,352,887 to Reid et al. issued Oct. 5, 1982. 
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development of therapeutic protocols. Moreover, these mod- 
els become essential in tailoring pharmaceuticals, i.e.; non- 
steroidal anti-inflammatories where the pharmaceutical may 
actually become detrimental to the chondrocyte by way of 
degradation into secondary metabolites. 
The artificial production of functional blood tissue such as 
normal bone marrow could be used in patients in need of 
bone marrow replacement which have lost the ability to 
produce the tissue. The tissue could be grown from a sample 
and transplanted back to the patient. Also, bone marrow 
material can be transplanted into a non-autologous recipient. 
SUMMARY OF THE INVENTION 
Aggregates of normal mammalian cells have been pro- 
duced in vitro for each of the three major tissue groups. The 
cell aggregates exhibited three dimensional tissue growth 
and functional interrelationship by cell to cell contact. 
Functional cells with normal morphology have been pro- 
duced for organ, structural and blood producing tissues. Cell 
function was in some cases confirmed immunohistochemi- 
cally by antibodies specific to particular cellular components 
characterizing cell types. 
The aggregates were produced under “microgravity cul- 
ture conditions” which can be microgravity or simulated 
microgravity. Simulated microgravity was created in unit 
gravity by controlling the horizontal rotation of a culture 
vessel containing normal mammalian cells, culture matrix 
and completely filled with culture media. In the preferred 
process a horizontally rotating wall culture vessel produced 
the simultaneous conditions of (1) collocation of cells and 
culture matrix with similar or differing sedimentation prop- 
erties in a similar spatial region, (2) freedom for three 
dimensional spatial orientation of tissues formed by the 
culturing of the cells and (3) low shear and essentially no 
relative motion of the culture environment with respect tQ 
the walls of the culture vessel. The culture conditions 
included mass transfer under microgravity conditions with 
exchange of nutrients for metabolic waste and appropriate 
gas exchange in the culture system. 
The process for producing the normal mammalian tissue 
is particularly unique in that the resultant product is normal 
tissue of a size of 2 millimeters and larger. The size of the 
tissue cultured is significant because assembly of three 
dimensional masses of this size is not possible without the 
complex functional interrelationship of the normal mamma- 
lian cells. 
Functional three dimensional organ tissue masses have 
been produced artificially from an inoculum of predomi- 
nantly normal differentiated epithelial cells and predomi- 
nantly normal differentiated mesenchymal cells. The epithe- 
lial and mesenchymal cells were preferably disassociated 
prior to introduction into the culture vessel. The epithelial 
&d mesenchymal cells were introduced in a vessd with a 55 
culture matrix preferably of generally spherical microcarri- 
ers. Tissue engineering was achieved by selected introduc- 
tion of the mesenchymal cells and culture matrix for a 
preselected culture period prior to transfer of epithelial cells 
A three dimensional normal organ tissue mass grew in 
association with the culture matrix having functional epi- 
thelial cells and functional mesenchymal cells. Also, the 
tissue developed cells immunochemically characterized as 
functional endothelial precursor cells in significantly greater 65 
numbers than were present in the initial inoculum. The organ 
tissue mass also developed cells immunochemically char- 
to the culture vessel. 60 
6 
acterized as functional angioblasts and cells that were immu- 
nochemically characterized as functional epithelial cell 
brush borders. Organized columnar cells were clearly vis- 
ible. The developing organ tissue included cells immu- 
5 nochemically characterized as basement membrane compo- 
nents. As the tissue masses grew anchored to microcarriers 
they were joined with cord-like structures of fibroblasts 
covered by epithelial cells. 
A preferred fluid media for mammalian organ tissue 
10 culture is a MEM (minimum essential medium) base with a 
tri-sugar supplement and fetal bovine serum. The preferred 
tri-sugar supplement is selected from mixtures of fructose, 
galactose and glucose. 
The organ tissue can be initiated by various normal 
l5 mammalian organ cells including skin, small intestine, pan- 
creas, liver, colon, and endocrine gland. Predominantly 
normal terminally differentiated cells were able to revert to 
a state that allowed interaction of a growing cellular mass 
capable of normal organ tissue evolution without using 
2o non-differentiated cells and without using cell types such as 
tumor cells that have abnormal cell growth characteristics. 
Artificially produced structural tissue has been produced 
in microgravity culture conditions from normal structural 
25 tissue. The three dimensional structural tissue mass devel- 
oped with functional chondrocytes and stromal cells with 
tissue calcification. The tissue exhibited matrix deposition 
including cells immunochemically characterized as produc- 
ing Type IV, Type IX and Type X collagen. The structural 
3o tissue is cultured in a vessel at microgravity conditions as 
described herein with a culture matrix. A preferred culture 
matrix was generally spherical microcarriers. An initial 
inoculum used in the process to produce the structural tissue 
mass was nonhuman embryonic cartilage cells disassociated 
Three dimensional mammalian blood tissue of normal 
origin has been produced artificially. The bone marrow 
tissue was prepared from normal bone marrow cells. The 
inoculum from the bone marrow include pleuripotential 
40 stem cells, fully matured white blood cells and red blood 
cells. The bone marrow cells were transferred into a culture 
vessel with Ruid culture media and culture matrix. Micro- 
gravity culture conditions as described herein were main- 
tained while three dimensional tissue growth was achieved. 
45 The culture matrix can be disc-shaped. The bone marrow 
can be encased in stromal-like matrices and introduced into 
the vessel. Also, culture matrix of Type I rat tail collagen and 
biopolymers can be used. 
Relatively large normal mammalian three dimensional 
50 tissue masses were cultured using microgravity culture 
conditions. The ability of the cells to grow into large 
aggregates supports the functional relationship achieved by 
cell to cell contact of normal cells. The process and normal 
tissue of this invention can be used advantageously as an in 
35 prior to transfer to the culture vessel. 
vitro produced mammalian product. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a view at 2 0 0 ~  magnification of a three dimen- 
FIG. 2 is a photograph of artificial normal organ tissue at 
FIG. 3 is a photograph of artificial normal organ tissue at 
FIG. 4 is a photograph of artificial normal organ tissue at 
sional artificial normal organ tissue mass. 
200x magnification. 
500x magnification. 
1 5 0 0 ~  magnification. 
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FIG. 5 is a photograph of artificial normal organ tissue at 
FIG. 6 is a photograph of artificial normal structured 
FIG. 7 is a photograph of artificial normal structural tissue 
FIG. 8 is a photograph of artificial normal structural tissue 
FIG. 9 is a photograph of artificial normal structural tissue 
FIG. 10 is a schematic drawing of the blood producing 
50x magnification. 
tissue at 5 0 0 ~  magnification. 
at 1500x magnification. 
at 200x magnification. 
at 1500x magnification. 
tissue cells and microcarriers. 
DETAILED DESCRIPTION OF THE INVEN- 
TION 
Aggregates of cells from the three major tissue groups 
were cultured in vitro. The artificially produced tissue 
masses exhibited normal morphology and cell function. 
Examples of organ tissue, structural tissue and blood tissue 
are described below. 
The artificially produced mammalian organ tissue was 
generated from normal small intestine epithelial and mes- 
enchymal cells. Human small intestine epithelial and mes- 
enchymal cells were obtained from normal organs of 
patients, predominantly organ transplant donors, with no 
evidence of disease. The cells were then propagated in 
culture. The cells were initiated and propagated in M3 media 
supplemented with 2% fetal bovine serum (FBS), designated 
M3:2, for epithelial cells or with 10% FBS, designated 
M3:10, for mesenchymal cells. M3 medium is a complex 
base medium supplemented with many growth factors and 
nutrients including L-Broth (tryptone broth), bovine pitu- 
itary extract, hydrocortizone, essential and non-essential 
amino acids, pentagastrin, epidermal growth factor, trans- 
ferrin, selenium, and insulin. Moyer, “Methods for Propa- 
gation and Characterization of Human GI and Other Cells 
for Study of HI,,’’ J. Rss. Cult. Meth., Vol. 13, pp. 107-116 
(1991). 
All cell cultures were grown in a Forma humidified CO, 
incubator with 95% air, 5% CO,, and constant atmosphere 
at a temperature of 37” C. Normal mesenchymal cells were 
passaged as required by enzymatic dissociation with a 
solution of 0.1 % Trypsin, 0.1% EDTA, for 15 minutes at 37” 
C. After incubation with the appropriate enzymes, the cells 
were centrifuged at 800xG for 10 minutes in Coming 
conical 15-ml centrifuge tubes. The cells were then resus- 
pended in fresh medium and diluted into Coming T-flasks 
with 25 ml of fresh growth medium. Small intestine epithe- 
lial cells were passaged by dilution at a 1:2 ratio into fresh 
M3:2 medium in T-flasks. Cultures of epithelial cells were 
derived from the ileum and jejunum of three male donors 
(22-35 years of age). Mesenchymal cells were obtained 
from the submucosa of five donors (4 males, 17-27 years 
old, and a 2-month-old female). 
Normal mesenchymal cells were removed from T-75 
flasks by enzymatic digestion, washed once with calcium- 
and magnesium-free PBS (CMF-PBS), and assayed for 
viability by Trypan Blue dye exclusion (GIBCO). Cells were 
held on ice in fresh growth medium until inoculation. In the 
preferred process the primary inoculum introduced into the 
culture vessel was 2x105 mesenchymal cells/ml in a 125-ml 
volume with 5 m g / d  Cytodex-3 microcarrier beads (Phar- 
macia, Piscataway, N.J.). Cytodex-3 microcarriers were 
Type I, collage-coated dextran beads, 175 microns in diam- 
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eter. After the primary inoculum was prepared for seeding, 
it was transferred to a culture vessel filled with culture media 
and cultured at microgravity conditions. 
In a preferred method the microgravity conditions were 
simulated in unit gravity by a horizontal rotating wall vessel 
(RWV). A preferred RWV bioreactor is described in U.S. 
Pat. No. 5,026,650 to Schwarz et al. issued Jun. 25,1991 and 
is incorporated by reference herein. The rotation of the 
culture vessel (bioreactor) was controlled to produce the 
simultaneous conditions of (1) collocation of cells and 
culture matrix with similar or differing sedimentation prop- 
erties in a similar spatial region, (2) freedom for three 
dimensional spatial orientation of tissues formed by the 
culturing of the cells and (3) low shear and essentially no 
relative motion of the culture environment with respect to 
the walls of the culture vessel. The trajectory of the cell 
aggregates was determined. The speed of the rotation of the 
culture vessel was increased if the cell aggregates fell 
excessively inward and downward on the downward side of 
the rotational cycle and excessively outward and insuffi- 
ciently upward on the upgoing side of the rotational cycle to 
prevent wall impact. The rotation of the culture vessel was 
decreased in response to excessive accumulation of tissue 
aggregation near the outer wall of the culture vessel so as not 
to restrict three dimensional growth. As the tissue aggregates 
grow the rotation was adjusted to obtain minimal collision 
frequency and intensity. 
The culture media used in the RWV can be varied. A 1 : 1 
mixture of M3:2 medium and standard minimal essential 
medium-alpha (MEM-alpha) (GIBCO) supplemented with 
10% FBS was used. A preferred media designated GTSF-2 
was found to meet the growth requirements of the system 
without the need for unique growth factors and other com- 
plex components found in other media including M3:2. The 
GTSF-2 media is a trisugar-based medium with glucose, 
galactose and fructose supplemented with 6% FBS. A pre- 
ferred formulation for GTSF-2 media is listed in Table 1 
below. The pH was adjusted to 7.4 with 1N NaOH. 
TABLE 1 
Component 
Tri-Sugar Based Medium GTSF-2 
Source/Order or 
Concentration Designation 
=-alpha supplemen- 
ted with 2.25 gmL 
NaHCO, 
L-15 
NaHCO, 
HEPES 
Folic acid 
0.5% Nicotinic acid 
Bactopeptone 
I-inositol 
Fructose 
Galactose 
D-Glucose 
300 mM L-Glutamine 
Gentamycin 
Fungizone 
Insulin-wansferrin- 
sodium-solenite 
Fetal bovine serum 
400 ml(40%) GIBC0/430-1900EB 
600 ml(60%) 
1.35 gmlliter 
3.0 gmlliter 
6.667 &liter 
0.667 myliter 
0.6 g d t e r  
0.024 gmlliter 
0.13 gm/liter 
0.25 gm/liter 
1.0 gm/liter 
10 ml/liter 
1 ml/liter 
2 myliter 
5 ml/liter 
GIBC0/430-1300EB 
Sigma/S-5761 
Research Or- 
ganicd6003H-2 
SigmaF-8758 
Sigma/N-4126 
Difco/O118-01 
SigmalI-5125 
Sigma/F-3510 
Sigma/G-5388 
Sigma/G-5250 
SigmalG-5763 
GIBC0/600-5750AD 
GIBC0/600-5295AE 
SigmaA- 1884 
60 ml (6%) Hyclone/A-1111-L 
The primary inoculum of mesenchymal cells was allowed 
to grow for a minimum of 2-3 days before the medium was 
changed. Then 2x10’ epithelial cells/ml were added pre- 
pared as described above for the mesenchymal cells. The 
organ tissue can be bioengineered to develop desired pat- 
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terns of cell layering by preselecting the introduction of the 
epithelial cells into the culture vessel. Also, the cells can be 
introduced essentially simultaneously into the vessel to 
produce normal organ tissue. 
Culture conditions included mass transfer with exchange 
of nutrients for metabolic waste and appropriate gas 
exchange in the culture system. Fresh medium was replen- 
ished by 65% of the total vessel volume each 20 to 24 hours. 
As metabolic requirements increased, fresh medium was 
supplemented with an additional 100 mg/dl of glucose. 
Viable cocultures grown in the RWVs were harvested over 
periods up to 45 days and prepared for various assays. 
The artificial organ tissue mass was produced in the RWV 
in both a 1 : 1 mixture of M3:2 and MEM alpha supplemented 
with 10% fetal bovine serum (Hyclone Laboratories, Logan, 
Utah) and tri-sugar based media shown in Table 1 on a 
preferred culture matrix of 5 m g / d  Cytodex-3 generally 
spherical microcaniers (Pharmacia, LKB). The three dimen- 
sional tissue cultures grown in the M3:2 and MEM media 
attained cell densities of 2.3-3.2~10’ cellslml and although 
the cultures did not reach plateau phase, suggesting the 
potential for continued growth, the epithelial cell contingent 
exhibited signs of considerable stress while the mesenchy- 
mal cells proliferated well. 
The preferred tri-sugar based media was found to meet the 
growth requirements without the need for multiple growth 
factors and supplements. The cultures in the tri-sugar based 
media produced slightly higher average cell densities, 4.6 to 
6 . 2 ~ 1 0 ~  cells/ml as compared to the M3:2 and MEM media 
which exhibited cell densities of 2.5-3.2~10~ cells/ml. The 
three dimensional tissue mass grown in the tri-sugar based 
media exhibited an epithelial cell component which 
appeared to proliferate in a more normal and appropriate 
fashion. The cultures were not grown to the plateau phase, 
indicating further capability for continued growth. The arti- 
ficial tissue did not reach maximum cell densities after 
38-45 days of culture. 
The tissue masses grew to relatively large sizes as com- 
pared to other in vitro methods. After 300 hours of culture 
the tissuehicrocarrier mass was about 0.2-0.3 cm in size 
with masses increasing to about 0.4-0.6 cm after approxi- 
mately 500 hours of culture and over 0.6 cm after 800 hours 
of culture. 
The epithelial cells and mesenchymal cells used to seed 
the cultures were irnmunophenotyped and compared to the 
three dimensional tissue cultured in the RWV. Samples were 
harvested at intervals during the culture process for immu- 
nocytochemical analysis. The antibodies used to immu- 
nochemically characterize the cell types are listed in Table 
2 below. 
TABLE 2 
ANTIBODES USED FOR 
lMMuN0cYT0cHEM1cAL ANALYSIS 
Antibody SourcdOrder No. or 
Specificity Dilution Designation 
TABLE 2-continued 
ANTIBODIES USED FOR 
IMMUNOCYTOCHEMICAL ANALYSIS 
5 
Antibody SourcelOrder No. 01 
Specificity Dilution Designation 
Pancytokeraiin prediluted DAKO, Inc.Ll824 60 
Vientin prediluted DAKO, Inc.Ll843 
Factor VIII prediluted DAKO, Inc.Ll809 
V i n  1:20 Chemicon, Temacria, 
Sucrase 1:20 A. Elbein, UTHSCSAlYT 
Angioblasts 1:20 Accurate Chem, Westbury, 
Laminin 1:20 ICN, Costa Mesa, CAl69-630 
CAIMAB 1671 
65 CA/HE3-5/47 
Fibronectin 1;20 US BIOCH, Cleveland, 
10 Proteoglycan 1;20 Biological Products for 
Collagen Type IV 1:20 DAKO, Inc./M785 
The keratin, vimentin, and Factor VIII antibodies detect 
epithelial, fibroblastic, and endothelial cells, respectively. 
l5 Villin is a cytoskeletal protein only found in epithelial cells 
from small intestine and colon. The angioblast marker is 
present in subsets of precursor endothelial cells, particularly 
dividing cells. Sucrase is an enzyme found in the epithelial 
cell brush border of the small intestine. Basement membrane 
20 and extracellular matrix components laminin, fibronectin, 
Collagen IV, and proteoglycan were also assayed to deter- 
mine their expression in the artificially produced three 
dimensional tissues. 
Cultured organ tissue grown on Cytodex-3 microcarriers 
25 in the RWV were fixed in OmniFix, an alcohol-based 
fixative not containing aldehydes or mercury (Xenetics 
Biochemic, Tustin, Calif.). At all times, extreme care was 
taken not to damage the delicate artificial tissue comprised 
of cellular material and microcanier beads. When an abun- 
30 dance of beads was present, the supernatant fluid was 
carefully decanted and a sample of beads was enclosed in a 
biopsy bag, then placed in a cassette to prepare a paraflin 
block. When bead clusters were scarce, a Shandon Cytob- 
lock Kit (Shandon Inc., Pittsburgh, Pa.) was used. Cassettes 
35 were processed in a standard tissue processor. Five-micron 
sections were cut from the paraflin-embedded tissues, depar- 
aflinized by standard procedures, then assayed by incubation 
with the test antibodies (Table 2) followed by use of the 
universal labeling streptavidin biotin (LSAB) kit (DAKO 
40 Inc., Carpenteria, Calif., No. K680), which detects mouse 
monoclonal and rabbit polyclonal antibodies. The immuno- 
cytophenotyping was confirmed by one positive and two 
negative controls. The positive control was normal tissue 
sections or normal cells positive for the primary antibody 
45 used. The negative controls were 1) PBS only, to test for 
false binding by “link” antibody and streptavidin, and 2) 
normal serum of the same species from which the primary 
antibody was prepared. 
Analysis by immunocytochemistry was used to confirm 
50 the ability of the seed cells to produce a three dimensional 
artificially produced tissue mass with functional epithelial 
cells and functional mesenchymal cells as well as functional 
precursor endothelial cells that were not present in the seed 
culture. As the culture progressed and the tissue mass grew 
Immunophenotyping of the cell types used to seed the 
coculture in the RWV confirmed the majority of epithelial 
and mesenchymal cells seeded were keratin and vimentin 
OW33752 
Science, Oxford, UKIMCA 326 
55 it included functional angioblasts. 
positive, respectively. In addition, the epithelial cells were at 
various stages of differentiation. Only a small percentage 
(<2%) of the cells was positive for Factor Vm, an endot- 
helial cell differentiation marker. Table 3 is a summary of the 
immunochemical staining reaction of the three dimensional 
tissue of the present invention. The tissue was harvested at 
various intervals up to 41 days as noted in Table 3. 
An increased percentage 210% of cells present in the 
masses consisted of endothelial cells which were Factor VIII 
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positive as confirmed by immunochemistry and growing as 
patches on the beads. Furthermore, a small percentage, 
1 4 %  of cells, showed de novo expression of the HE3 
angioblast antigen which was not present in the seed cultures 
of mesenchymal cells confirming the presence of angioblasts 
in the tissue by immunochemistry. Functional cell brush 
borders were confirmed immunochemically by the presence 
of sucrase. 
FIG. 1 is a photograph of the small intestine artificially 
produced organ tissue at 2 0 0 ~  magnification showing the 
three dimensional cell aggregate generally indicated by the 
arrows. FIG. 2 is a photograph of the small intestine organ 
tissue. The triangular markers at 2 and 4 in the photograph 
are for reference on the microcarriers. A mass of epithelial 
cells is shown at 6.  Elongated mesenchymal cells are grow- 
ing on the microcarriers as shown at 8 and 10. FIG. 3 is a 
higher magnification (500x) of the epithelial mass shown at 
6 in FIG. 2. FIG. 4 shows the organized columnar epithelial 
cells of the small intestine organ tissue at arrows 12 and 14. 
FIG. 5 shows the three dimensional organ tissue masses 
joined by cord-like structures of fibroblasts (mesenchymal 
cells) covered by epithelial cells. 
12 
sprinkled with a thin layer of silver paint on a specimen stub, 
dried, coated by vacuum evaporation with platinum-palla- 
dium alloy, and then examined in the JEOL T330 Scanning 
electron microscope at an accelerating voltage of 5 to 10 kV. 
Micrographs taken of 6- to 7-day cocultures showed 
partial coverage of the microcarriers by normal small intes- 
tine mesenchymal cells. Additionally, large developing 
masses of small intestine epithelium were evident, growing 
on the microcarrier beadpacks. Samples harvested at 
10 approximately 12 days of culture contained small microcar- 
rier packs which were totally engulfed in proliferating small 
intestine epithelium. Micrographs of samples at 13 days 
displayed large tissue-like masses that were entirely covered 
with small intestine epithelium grown on a base layer of 
15 mesenchymal cells. Areas of organized columnar epithelium 
were prominent. As the cultures matured into mid- and 
late-stage cultures, extremely complex tissue-like masses 
comprised of mesenchymal and epithelial cells were seen 
from approximately 16 days of culture until termination at 
20 41 days. These tissues were assembled from smaller masses 
which were joined by cord-like structures of fibroblasts and 
covered by epithelial cells several layers deep. In addition, 
5 
TABLE 3 
SUMMARY OF IMMUNOCHEMICAL STAINING ON TISSUE GROWTH IN RWV* 
Specificity or Days Grown in RWV 
Antibodies Cell Stained 13 23 25 37 41 
Keratin Epithelial, Cytoskeletal ++t ttt ++ ++ ++ 
Vientin Fibroblasts, some endothelial ttt * ++ +!- +!- 
Factor W I  Endothelial ++ ttt +!- ++ ++ 
Villin Epithelial, smal l  intestine + + + + + 
HE3 Angioblasts ++ ++ 
Sucrase Small intestine, ttt + +!- ++ ++ 
Laminin Basement membrane + + + ++ 
Fibronectin Basement membrane + + ++ ++ - 
Proteoglycan Extracellular matrix - K H * i i + + + H + - K H  
Collagen Extracellular +!- + + +!- ND 
Type N matrix 
- - - 
cell brush border 
- 
*Slides were observed and scored on arelative scale as - (negative) to -KH (maximum staining; very dark positive 
for >90% of the cells); + indicates weaker staining for -25-50% of the cells; 
++ indicates moderate staining for greater than 5&75% of the cells. 
45 
Samples from the RWV cultures were taken for scanning available microcarriers were drawn to the surface of these 
electron microscopy at the same times as those taken for large masses which were approximately 0.3 to 0.5 cm in 
immunocytochemistry. After removal from the reactor ves- diameter. Finally, columnar epithelium was observed to be 
sels, samples were washed once with CMF-PBS. The growing even in the recessed areas of the microcarrier bead 
samples were suspended in a buffer containing 3% glutaral- packs. 
dehyde and 2% paraformaldehyde in 0.1M cacodylate buffer 50 The artificially produced mammalian structural tissue was 
at pH 7.4, then rinsed for 5 minutes with cacodylate buffer generated from normal mouse embryonic femurs. The fetal 
three times and postfixed with 1% osmium tetroxide (Elec- cells are a mixture of chondrocytes and stromal cells. The 
tron Microscopy Sciences, Fort Washington, Pa.) in cacody- cells were placed in a standard media commonly designated 
late buffer for 1 hour. Samples were then rinsed for 5 as CMRL 1066 (Gibco Labs) containing 10% Fetal Bovine 
minutes with distilled water three times and then treated for 55 Serum. The cells were disassociated by standard enzymatic 
10 minutes with Millipore (Millipore Corp., Bedford, Mass.) digestion. The single cells produced by enzymatic digestion 
(0.2 p) filtered, saturated solution of thiocarbohydrazide were washed several times in PBS and transferred into a 
(Electron Microscopy Sciences), then washed for 5 minutes culture vessel with fluid culture media. The preferred culture 
with distilled water five times and fixed with 1% buffered vessel is described in U.S. Pat. No. 5,026,650 and referenced 
osmium tetroxide for 10 minutes. This last step was neces- 60 above. The vessel was steam sterilized by autoclaving at 
sary to prevent the microcarriers from collapsing. Samples standard temperature and pressure prior to transfer of the 
were then rinsed with distilled water three times and dehy- cells. 
drated with increasing concentrations of EtOH followed by A preferred culture matrix of generally spherical micro- 
three changes in absolute methanol. After transfer to 1, 1, 1, carrier Cytodex-3 beads were transferred into the culture 
3, 3, 3-hexamethytdisilazane (HMDS) (Electron Micros- 65 vessel. The approximate total cell inoculum was 132,000, 
copy Sciences) samples were allowed to soak for 10 min- 000 at a ratio of 30 cells per Cytodex-3 microcarrier bead. 
Utes, drained, and air dried overnight. Dried samples were The bead concentration of the vessel was 10 m g / d  (4000 
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beaddmg). The culture media in the vessel was CMRL 1066 
with ascorbic acid 10 mg/ml added. 
Microgravity conditions were simulated in culture vessel 
as described and referenced herein. The vessel provided the 
quiescent well-perfused environment for maintenance of 5 
cell surface receptors and undisturbed cell-to-cell co-loca- 
tion. Co-location is important for autodne-paracrine factor 
biodegradable such as suture materials. Cross-linked poly- 
mers such as collagen, fibronectin and mixtures thereof may 
be used. These matrices may have spherical diameters 
ranging from 1 millimeter to 10 millimeters and include the 
necessary cellular constituents to facilitate primary bone 
marrow Culture. Cytodex-3 microcarriers Can be introduced 
into the vessel at a density of 5 m g / d .  Bone marrow cells 
formation and exchange between cellular types, and numr- contained in the matrix Or in suspension are 
ing of differentiation with matrix deposition. cultured at microgravity conditions and mass transfer as described herein and the incorporated references. The cells were cultured for up to 65 days. The tissue masses 10 Early in the initiation it is preferable that the cells are grew to at least 0.4 cm in length after lo00 hours of culture. allowed to grow and metabolize without sampling intemp- 
by normal inoculation. Consequently, cellular aggregates are not dis- 
sue with deification was Produced. Also, ProteoglYcan 15 media repletion. After the lag phase, media repletion is 
deposition was identified. The normal Pattern of TYPe 11 based upon requirements as previously described. Cellular 
collagen deposition followed by down regulation of Type phenotyping is carried Out by flow cytometry and light 
collagen deposition and enhanced formation of Type IX and microscopy. 
Type X collagen was observed. FIG. 10 is a schematic drawing of the bone marrow cell 
Photographs taken during the culture period of the struc- 20 production. The disc-shaped culture matrices are shown at 
turd cells show the growth and normal development of the 30,32 and 34. The bone marrow cells are shown as circular 
tissue. FIG. 6 is a micrograph taken at 500x magnification figures at 3 6 3 8  and 40. The arrows with the GF generally 
at 300 to 600 hours of culture of normal fetal mouse indicate the excretion of growth factors from the normal 
chondrocytes. The cells grew around the generally spherical bone marrow Cells that ~ ~ h a n c e  tissue growth in the Culture 
microcarriers. FIG. 7 is a higher magnification showing 25 system. 
preliminary calcification at the arrow 20. FIGS. 8 and 9 were In the case of preparing bone marrow for recipients, 
taken after to lloo hours of culture with differentiated volumes are expanded as cellular densities or metabolic 
upon the rotating vessel's ability to suspend large aggre- 
gates, in which case if unable to suspend large aggregates, stromal cells are show in FIG. 9 at 24. 
human bone marrow smples Or Other Of mamma- vessels. If the metabolic requirements were such that mass 
lian Origin. Human bone marrow are Obtained by transfer of oxygen and removal of carbon dioxide were not 
standard clinical techniques under aseptic conditions. In sufficient to maintain cellular growth and expansion, then 
general, a bone marrow to01 is used to puncture the bone and cells would be &quoted into additional vessels. 
Obtain a bone marrow The examples included are not intended to limit the scope 
normd constituents. The normal constituents Will include, ofthe present invention. Normal mammalian cells have been 
but are not limited to: pleuripotential stem cells, fully cultured to produce aggregates of cells of three dimensional 
maturated white blood cells and red blood cells, stromal tissue masses. Other substitutions, modifications and varia- 
components, and cells in intermediate stages of maturation. tions are apparent to those skilled in the art without depart- 
Laboratory animals such as mice can be used as a source 40 ing from the disclosure and scope of the invention. 
of bone marrow for selected studies. After sacrificing mice, What we claim is: 
the femur and tibia are removed and placed in IxCalcium- 1. A process for producing aggregates of non-neoplastic 
and Magnesium-free PBS with 200 pg/ml pen-strep. Muscle 
is removed and endcaps of the bones are cut. With a syringe (a) isolating non-neoplastic mammalian cells; 
and 26G needle, the bone is flushed with cold complete 45 (b) inoculating the isolated, non-neoplastic cells into a 
growth medium known to those skilled in the art such as culture vessel containing culture media and a culture 
CMRL 1066. Cells are then poured through collector screens matrix; 
to remove large pieces of tissue and suspended cells are (c) culturing the non-neoplastic cells under microgravity 
placed in 50-cc sterile tubes on cold complete growth culture conditions; and 
medium. Cells are washed and centrifuged three times to 50 (d) maintaining the microgravity culture conditions 
insure no contamination. Cells are not treated with any whereby three dimensional tissue growth is achieved 
reagent to remove red blood cells. thereby producing aggregates of non-neoplastic mam- 
The preferred culture vessel is described in U.S. Pat. No. malian cells. 
5,026,650 previously cited and incorporated by reference 2. The process of claim 1 wherein the culture matrix 
herein. A fluid culture media is introduced into the sterilized 55 comprises spherical microcarriers. 
vessel. A preferred fluid culture media is a standard tissue 3. The process of claim 1 wherein the microgravity 
culture media commonly designated as WM1-  1640 (avail- culture conditions are created by the culture vessel. 
able from Gibco and other sources). 4. The process of claim 1 wherein the microgravity 
cells are then transferred to fluid Culture COXlditiOnS are created by Simulating miCrOgraVity. 
culture medium and suspended, Suspended cells are trans- 60 5. The Process of claim 1 wherein miCWravitY Culture 
fern&, at approximate densities of 1x106 cells/&, to the conditions are created by a horizontal rotating wall culture 
culture vessel. various cell matrices can be used. The vessel in unit gravity, and wherein the horizontal rotation of 
collected bone marrow cells can be encased in swomal-like the culture vessel is controlled to produce the simultaneous 
matrices. The matrices can be disc-shaped. Other matrices conditions Of: 
are generally known can be used including, but are not 65 
limited to, collagen matrices of Type I rat tail collagen or 
other biopolymeric matrices. The biopolybers used can be 
The Of was evidenced tion. The first sampling may begin one to seven days after 
formation and CdlagineOUS tissue substructures. Also, tis- turbed and bone marrow growth factors are not diluted by 
Of the chondrocyte and stromal 
fibroblastic chon&ocytes shown in FIG. 9 at 22. Also, requirements dictate. The limited parameters may depend 
The produced tissue can be from 30 smaller aggregates would be distributed though several 
that is fully inclusive of 35 
mu-~~malian Cells comprising: 
The sterile bone 
(a) collocation of cells and culture matrix with similar or 
differing sedimentation properties in a similar spatial 
region, 
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(b) freedom for three dimensional spatial orientation of 
tissues formed by the culturing of the cells, and 
(c) low shear and essentially no relative motion of the 
culture environment with respect to the walls of the 
culture vessel. 
6. The aggregates of non-neoplastic mammalian cells 
produced by the process of claim 2 whereby the three 
riers. 
produced by the process of claim 3 wherein the culture 
matrix comprises spherical microcarries and whereby the (a) collocation of cells and culture matrix with similar or 
three dimensional tissue forms masses anchored to the differing sedimentation properties in a similar spatial 
microcarriers. region, 
(b) freedom for three dimensional spatial orientation of 
produced by the process of claim 4 wherein the culture tissues formed by the culturing of the cells, and 
(c) low shear and essentially no relative motion of the matrix comprises spherical microcarries and whereby the 
culture environment with respect to the walls of the three dimensional tissue forms masses anchored to the 
culture vessel. microcarriers. 
produced by the process of claim 5 wherein the culture 2o structural cells are 
three dimensional tissue forms masses anchored to the 
microcarriers. 
organ tissue comprising: 
(d) maintaining the micro gravity culture conditions 
whereby three dimensional tissue growth is achieved 
thereby producing non-neoplastic mammalian struc- 
turd tissue. 
15. The process of claim 14 wherein the culture matrix 
16. The process of claim 14 wherein microgravity culture 
vessel in unit gravity, and wherein the horizontal rotation of 
conditions Of: 
comprises Spherical microcarriers. 
dimensional tissue forms masses anchored to the microcar- conditions are created by a horizontal rotating wall culture 
7. The aggregates of non-neoplastic mammalian cells 1o the culture vessel is controlled to produce the simultaneous 
8. The aggregates of non-neoplastic mammalian cells 15 
9. The aggregates Of non-neoplastic mammalian 17, The process of claim 14 wherein the non-neoplastic 
embryonic structural cells. 
Illatrix comprises spherical microcarries and whereby the 18. The process of claim 14 wherein the non-neoplastic 
mammalian structural cells are nonhuman embryonic carti- 
lage cells. 
duced by the process of claim 15 whereby the three dimen- 
(a) isolating non-neoplastic, differentiated epithelial cells; sional tissue forms maSSeS anchored to the microcarriers. 
(b) isolating non-neoplastic, differentiated mesenchymal 20. The non-neoplastic mammalian structural tissue pro- 
cells; duced by the process of claim 15 whereby the three dimen- 
(c) inoculating the isolated, non-neoplastic epithelial cells sional tissue forms masses anchored to the microcarriers and 
and the isolated, non-neoplastic mesenchymal cells into 30 wherein the structural tissue comprises chondrocytes and 
a horizontal rotating wall culture vessel containing stromal cells. 
culture media and a culture matrix; 21. The non-neoplastic mammalian structural tissue pro- 
(d) culturing the non-neoplastic epithelial cells and the d ~ e d  by the Process of claim 15 whereby the three dimen- 
wherein the structural tissue further comprises cells with 
calcification. 
22. The non-neoplastic mammalian structural tissue pro- 
duced by the process of claim 15 whereby the three dimen- 
sional tissue forms masses anchored to the microcarriers and 
matrix 40 wherein the structural tissue further comprises cells which 
produce Type IV collagen. comprises spherical microcarriers. 
23. The non-neoplastic mammalian structural tissue pro- 
vessel in unit gravity, and wherein the horizontal rotation of 45 sional tissue forms masses anchored to the microcarriers and 
the culture vessel is controlled to produce the simultaneous wherein the structural tissue further comprises which 
produce Type M collagen. conditions of: 24. The non-neoplastic mammalian structural tissue pro- 
(a) collocation of cells and culture matrix with similar or duced by the process of claim 15 whereby the three dimen- 
differing sedimentation properties in a similar spatial sional tissue forms anchored to the and 
50 wherein the structural tissue further Comprises cells which region, 
tissues formed by the culturing of the cells, and 25. A process for producing non-neoplastic mammalian 
culture environment with respect to the walls of the 55 (a) isolating non-neoplastic mammalian cartilage cells; 
(b) inoculating the isolated, non-neoplastic mammalian culture vessel. 
structural cells into a culture vessel containing culture 
media and a culture matrix; 
cells under microgravity culture conditions wherein 
microgravity culture conditions are created by a hori- 
zontal rotating wall culture vessel in unit gravity, and 
wherein the horizontal rotation of the culture vessel is 
controlled to produce the simultaneous conditions of: 
(i) collocation of cells and culture matrix with similar 
or differing sedimentation properties in a similar 
spatial region, 
10. A process for Producing non-neo~lastic mammalian 19. The non-neoplastic mammalian structural tissue pro- 
25 
non-neoplastic mesenchymal cells under microgravity 35 sional tissue forms masses anchored to the microcarriers and 
culture conditions; and 
(e) maintaining the microgravity culture conditions 
whereby three dimensional tissue growth is achieved 
thereby producing non-neoplastic mammalian organ 
tissue. 
ll. The process of claim 
12. The process of claim 10 wherein microgravity culture 
wherein the 
conditions are created by the horizontal rotating wall culture duced by the process of claim l5 whereby the three dimen- 
(b) freedom for three dimensional spatid orientation of 
(c) low shear and essentially no relative motion of the 
produce Type x collagen. 
cartilage tissue comprising: 
13. The non-neoplastic mammalian organ tissue produced 
by the process of claim 11 whereby the three dimensional 
tissue forms masses anchored to the microcarriers. 
structural tissue comprising: 
14. A process for producing non-neoplastic mammalian (') the non-neoplastic mammalian structural 
60 
(a) isolating non-neoplastic mammalian structural cells; 
(b) inoculating the isolated, non-neoplastic mammalian 
structural cells into a culture vessel containing culture 
media and a culture matrix; 
(c) culturing the non-neoplastic mammalian structural 
cells under microgravity culture conditions; and 
65 
5,496,722 
17 18 
(ii) freedom for three dimensional spatial orientation of 
tissues formed by the culturing of the cells, and 
(iii) low shear and essentially no relative motion of the 
culture environment with respect to the walls of the 
culture vessel; and 5 a disc-shaped biopolymer. 
(d) maintaining the micro gravity culture conditions 
whereby three dimensional tissue growth is achieved 
turd tissue. 
32. The process of claim 29 wherein the isolated non- 
neoplastic mammalian bone marrow cells are encased in a 
stroma-like matrix prior to inoculation. 
33. The process of claim 29 wherein the culture matrix is 
34. The non-neoplastic mammalian blood tissue produced 
by the process of claim 30 whereby the three dimensional 
tissue 
by the process of claim 31 wherein the culture matrix 
26. The process of claim 25 wherein the culture matrix 10 comprises spherical microcaniers and whereby the three 
comprises spherical microcarriers. dimensional tissue forms masses anchored to the microcar- 
27. The process of claim 25 wherein the non-neoplastic +rs, 
mammalian cartilage cells are nonhuman embryonic carti- 36. A non-neoplastic mammalian organ tissue comprising 
lage cells. a three dimensional tissue mass anchored to spherical micro- 
28. The non-neoplastic mammalian cartilage tissue pro- l5 carriers wherein said three dimensional tissue mass is pro- 
duced by the process of claim 26 whereby the three dimen- duced by the process comprising: 
sional tissue forms masses anchored to the microcarriers. (a) inoculating isolated non-neoplastic epithelial cells and 
29. A process for producing non-neoplastic mammalian isolated non-neoplastic mesenchymal cells into a hori- 
blood tissue comprising: zontal rotating wall culture vessel containing culture 
(a) isolating non-neoplastic mammalian bone marrow 20 media and spherical microcarriers; 
cells; (b) culturing the isolated non-neoplastic epithelial cells 
(b) inoculating the isolated, non-neoplastic mammalian and the isolated non-neoplastic mesenchymal cells 
bone marrow cells into a culture vessel containing under microgravity conditions; and 
culture media and a culture matrix; (c) maintaining the microgravity culture conditions 
(c) culturing the non-neoplastic mammalian bone marrow 25 whereby three dimensional tissue growth is achieved 
cells under microgravity culture conditions; and thereby producing said three dimensional tissue mass 
anchored to the microcamiers. (d) maintaining the microgravity culture conditions 
whereby three dimensional tissue is achieved 37. The non-neoplastic mammalian organ tissue of claim 
thereby producing non-neoplastic mammalian blood 3o 36 wherein the three dimensional tissue mass further com- 
prises non-neoplastic endothelial precursor cells. tissue. 38. The non-neoplastic mammalian organ tissue of claim 
36 wherein the three dimensional tissue mass further com- 
prises non-neoplastic angioblasts. 
36 wherein said organ tissue is selected from the group 
endocrine gland. 
36 wherein the three dimensional tissue 
consist of fibroblasts covered by epithelial cells. 
41. The non-neoplastic mammalian organ tissue of claim 
36 wherein the three dimensional tissue mass further com- 
anchored to the microcaniers, 
thereby producing non-neoplastic strUc- 35. The non-neoplastic mammalian blood tissue produced 
30. The process of claim 29 wherein the culture matrix 
comprises spherical microcarriers. 
31. The process of claim 29 wherein microgravity culture 
conditions are created by a horizontal rotating wall culture 35 
vessel in unit gravity, and wherein the horizontal rotation of 
conditions of: 
39. The non-neoplastic mammalian Organ tissue Of 
the culture vessel is controlled to produce the simultaneous consisting of skin, small intestine, pancreas, liver, colon and 
40. The non-neoplastic mammalian organ tissue of claim 
is joined (a) collocation of cells and culture matrix with similar or 
differing sedimentation properties in a ‘Patid 40 together by cord-l&e structures and said cord-like structures 
region, 
(b) freedom for three dimensional spatial orientation of 
tissues formed by the culturing of the cells, and 
(c) low shear and essentially no relative motion of the 45 prises basement membrane components. 
culture environment with respect to the walls of the 
culture vessel. * * * * *  
